Form 4: Merit Medical Systems Director McDonnell Receives Stock Grant

Director Michael R. McDonnell of Merit Medical Systems Inc. received 2,152 restricted stock units (RSUs) on May 15, 2025, which will vest on May 15, 2026, subject to continued service.

Summary

• Michael R. McDonnell, a director of Merit Medical Systems Inc. (MMSI), filed a Form 4 on May 19, 2025.
• The filing reports a transaction on May 15, 2025, where McDonnell received 2,152 restricted stock units (RSUs).
• These RSUs were granted under the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan.
• The RSUs vest on May 15, 2026, contingent upon McDonnell's continued service to the company through the vesting date.
• Following the reported transaction, McDonnell beneficially owns 9,895 shares of common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects standard executive compensation practices and aligns director interests with company performance.

Positives

• The grant of RSUs aligns the director's interests with the long-term performance of the company.
• Continued service requirement ensures commitment to the company's success.

Risks

• The vesting of the RSUs is contingent upon continued service, creating a potential risk if the director leaves the company before the vesting date.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the RSUs.

Industry Context

Stock grants are a common form of executive compensation in the medical device industry, aligning management's interests with shareholder value.

Comparison to Industry Standards

• Stock grants are a typical component of executive compensation packages in publicly traded companies, particularly in the medical device sector.
• Companies like Medtronic, Stryker, and Boston Scientific also utilize stock grants and options as part of their long-term incentive plans to retain and motivate key personnel.
• The size of the grant is likely determined by a number of factors including company performance, individual contribution, and industry benchmarks for executive compensation.

Stakeholder Impact

• The stock grant aligns the director's interests with those of the shareholders, potentially driving long-term value creation.

Key Dates

Keywords

Form 4, restricted stock units, RSUs, Merit Medical Systems, MMSI, director, Michael R. McDonnell, beneficial ownership, equity compensation, stock grant